Paysign, Inc. (PAYS)
| Market Cap | 314.19M +154.2% |
| Revenue (ttm) | 91.47M +43.4% |
| Net Income | 10.40M +70.8% |
| EPS | 0.17 +56.6% |
| Shares Out | 55.91M |
| PE Ratio | 32.75 |
| Forward PE | 24.43 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 494,620 |
| Open | 5.80 |
| Previous Close | 5.79 |
| Day's Range | 5.44 - 5.89 |
| 52-Week Range | 3.08 - 8.88 |
| Beta | 0.72 |
| Analysts | Strong Buy |
| Price Target | 10.00 (+77.94%) |
| Earnings Date | May 12, 2026 |
About PAYS
Paysign, Inc. provides prepaid card programs, patient affordability offerings, digital banking, life science software technology solutions, and integrated payment processing services for businesses, consumers, and government institutions in the United States. The company offers solutions for corporate rewards, prepaid gift cards, general-purpose reloadable debit cards, employee incentives, consumer rebates, donor compensation, clinical trials, healthcare reimbursement payments and pharmaceutical payment assistance, and demand deposit accounts a... [Read more]
Financial Performance
In 2025, Paysign's revenue was $82.03 million, an increase of 40.50% compared to the previous year's $58.38 million. Earnings were $7.55 million, an increase of 97.90%.
Financial StatementsAnalyst Summary
According to 2 analysts, the average rating for PAYS stock is "Strong Buy." The 12-month stock price target is $10.0, which is an increase of 77.94% from the latest price.
News
Paysign reports Q1 EPS 9c vs. 5c last year
Reports Q1 revenue $28.04M vs. $18.6M last year. “Paysign (PAYS) delivered a strong start to 2026, with exceptional top- and bottom-line results that are consistent with our strategic direction and…
Paysign sees FY26 EPS 21c-26c
Sees revenue $106.5M-$110.5M. Sees adjusted EBITDA $30M-$33M. “Our first quarter results exceeded guidance across every line of the income statement,” commented Jeff Baker, Chief Financial Officer of ...
Paysign sees Q2 EPS 6c-7c
Sees Q2 revenue $26.2M-$26.7M. Sees Q2 adjusted EBITDA $7.7M-$8.5M.
Paysign Earnings Call Transcript: Q1 2026
Record Q1 results with revenue up 50.8% and net income up 110% year-over-year, driven by strong growth in patient affordability and plasma segments. Guidance raised for 2026, with robust pipelines and no expected impact from plasma center closures.
Paysign's Patient Affordability Drives 51% Revenue Growth and Significant Margin Expansion for First Quarter 2026
HENDERSON, Nev.--(BUSINESS WIRE)--Paysign's Patient Affordability Drives 51% Revenue Growth and Significant Margin Expansion for First Quarter 2026.
Paysign management to meet with Barrington
Meeting to be held in Minneapolis on May 18 hosted by Barrington.
Paysign to Host First Quarter 2026 Earnings Call
HENDERSON, Nev.--(BUSINESS WIRE)--Paysign to Host First Quarter 2026 Earnings Call.
Paysign price target raised to $11 from $10 at Lake Street
Lake Street analyst Jacob Stephan raised the firm’s price target on Paysign (PAYS) to $11 from $10 and keeps a Buy rating on the shares. The firm, which is raising…
Paysign Earnings Call Transcript: Q4 2025
Revenue grew 40.5% to $82M in 2025, with net income up 98% and strong margin expansion. Patient Affordability revenue surged 168%, and 2026 guidance calls for 30–35% growth, driven by both plasma and pharma segments.
Paysign reports Q4 adjusted EPS 9c, consensus 3c
Reports Q4 revenue $22.76M, consensus $21.55M. “2025 was a standout year for Paysign (PAYS), delivering record top- and bottom-line results,” commented Mark Newcomer, President and CEO of Paysign. “We...
Paysign sees Q1 adjusted EPS 15c-16c, consensus 7c
Sees Q1 revenue $27M-$27.5M, consensus $23.83M.
Paysign sees FY26 adjusted EPS 49c-53c, consensus 24c
Sees FY26 revenue $106.5M-$110.5M, consensus $97.48M. v
Paysign sees FY26 adjusted EPS 49c-53c, consensus 24c
Sees FY26 revenue $106.5M-$110.5M, consensus $97.48M.
Paysign, Inc. Reports Fourth Quarter and Full-Year 2025 Financial Results; Patient Affordability Drives 40% Revenue Growth and Significant Margin Expansion
HENDERSON, Nev.--(BUSINESS WIRE)--Paysign, Inc. Reports Fourth Quarter and Full-Year 2025 Financial Results.
Paysign to Host Fourth Quarter and Full Year 2025 Earnings Call
HENDERSON, Nev.--(BUSINESS WIRE)--Paysign to Host Fourth Quarter and Full Year 2025 Earnings Call.
Paysign, Inc. to Present at the Oppenheimer 11th Annual Emerging Growth Conference
HENDERSON, Nev.--(BUSINESS WIRE)--Paysign, Inc. to Present at the Oppenheimer 11th Annual Emerging Growth Conference.
Paysign, Inc. Announces 2025 Performance Analysis of Patient Affordability Solutions
HENDERSON, Nev.--(BUSINESS WIRE)--Paysign, Inc. Announces 2025 Performance Analysis of Patient Affordability Solutions.
Paysign Transcript: 17th Annual Southwest IDEAS Conference
Leadership with deep payments and banking expertise drives growth in patient affordability and plasma payment sectors. Proprietary technology and high client retention fuel strong financial performance, with revenue and margins rising year-over-year.
Paysign, Inc. to Present at the 17th Annual Southwest IDEAS Investor Conference
HENDERSON, Nev.--(BUSINESS WIRE)--Paysign, Inc. to Present at the 17th Annual Southwest IDEAS Investor Conference.
Paysign Earnings Call Transcript: Q3 2025
Q3 2025 saw record revenue and profit growth, led by a 142% surge in patient affordability revenue and continued expansion in plasma. Guidance for 2025 was raised, with strong margin improvements and robust cash flow, despite plasma industry oversupply and regulatory delays for new tech platforms.
Paysign reports Q3 adjusted EPS 8c, two estimates 4c
Reports Q3 revenue $21.6M, consensus $19.92M. “Q3 2025 proved once again to be a record-breaking quarter for Paysign (PAYS),” said Mark Newcomer, President and CEO. “Our revenue soared to $21.6…
Paysign sees FY25 adjusted EPS 32c-34c, consensus 17c
Raises FY25 revenue view to $80.5M-$81.5M from $76.5M-$78.5M, consensus $77.53M.
Paysign, Inc. Reports Third Quarter 2025 Financial Results
HENDERSON, Nev.--(BUSINESS WIRE)--Paysign, Inc. Reports Third Quarter 2025 Financial Results.
Paysign to Host Third Quarter 2025 Earnings Call
HENDERSON, Nev.--(BUSINESS WIRE)--Paysign to Host Third Quarter 2025 Earnings Call.
Paysign, Inc. Appoints Jose Garcia as Executive Vice President, Life Science Solutions
HENDERSON, Nev.--(BUSINESS WIRE)--Paysign, Inc. Appoints Jose Garcia as Executive Vice President, Life Science Solutions.